Exagen Diagnostics, Inc.
Records under this name other than patents Exagen Diagnostics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Exagen Diagnostics, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,132,813 | Methods for Diagnosing Systemic Lupus Erythematosus Formerly held In force · High confidence | In force | High confidence | |
| US 11,360,099 | Methods for Diagnosing Systemic Lupus Erythematosus Formerly held In force · High confidence | In force | High confidence | |
| US 11,761,965 | Methods for Diagnosing Systemic Lupus Erythematosus Formerly held In force · High confidence | In force | High confidence | |
| US 11,885,812 | Methods for Diagnosing Systemic Lupus Erythematosus Formerly held In force · High confidence | In force | High confidence | |
| US 12,372,535 | Methods for Diagnosing Systemic Lupus Erythematosus Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,531,033 | Methods for treating and diagnosing Systemic Lupus Erythematosus Formerly held In force · High confidence | In force | High confidence | |
| US 12,449,427 | Methods for Treating and Diagnosing Systemic Lupus Erythematosus Formerly held In force · High confidence | In force | High confidence | |
| US 7,698,071 | Methods and Devices Relating to Estimating Classifier Performance Term ended Term ended Mar 28, 2022 · High confidence | Term ended | Term ended Mar 28, 2022 | High confidence |
| US 7,561,971 | Methods and Devices Relating to Estimating Classifier Performance Lapsed on the fee record Ended Jul 14, 2017 · High confidence | Lapsed on the fee record | Ended Jul 14, 2017 | High confidence |
| US 7,557,198 | Acute Myelogenous Leukemia Biomarkers Lapsed on the fee record Ended Jul 7, 2017 · High confidence | Lapsed on the fee record | Ended Jul 7, 2017 | High confidence |